Overview
Marc Bardou practices in Dijon, France. Mr. Bardou is rated as a Distinguished expert by MediFind in the treatment of Peptic Ulcer. His top areas of expertise are Peptic Ulcer, Gastrointestinal Bleeding, Hypomelanosis of Ito, Endoscopy, and Colonoscopy.
His clinical research consists of co-authoring 116 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 14 articles in the study of Peptic Ulcer.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Gastrointestinal BleedingMr. Bardou isDistinguished. Learn about Gastrointestinal Bleeding.
- Peptic UlcerMr. Bardou isDistinguished. Learn about Peptic Ulcer.
- Advanced
- Hypomelanosis of ItoMr. Bardou isAdvanced. Learn about Hypomelanosis of Ito.
- Increased Head CircumferenceMr. Bardou isAdvanced. Learn about Increased Head Circumference.
- Megalencephaly-Capillary Malformation Syndrome
- Experienced
- ADULT SyndromeMr. Bardou isExperienced. Learn about ADULT Syndrome.
- Camptodactyly Fibrous Tissue Hyperplasia Skeletal Dysplasia
- Camptodactyly Syndrome Guadalajara Type 1
- Camptodactyly Syndrome Guadalajara Type 2
- Camptodactyly TaurinuriaMr. Bardou isExperienced. Learn about Camptodactyly Taurinuria.
- Cervical CancerMr. Bardou isExperienced. Learn about Cervical Cancer.